Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
48.15 USD | +8.32% | -.--% | +17.44% |
16.05. | Basilea erhält dank starker Cresemba-Umsätze in Asien-Pazifik/China Meilenstein | AW |
16.05. | Basilea Pharmaceutica erhält Meilensteinzahlung von Pfizer für Cresemba-Verkäufe | MT |
Performance
1 Tag | +8.32% | ||
1 Monat | +8.32% | ||
3 Monate | +18.16% | ||
6 Monate | +17.44% | ||
Laufendes Jahr | +17.44% | ||
1 Jahr | -3.70% | ||
3 Jahre | +4.59% | ||
5 Jahre | +21.96% | ||
10 Jahre | -57.76% |
Volumen
MärkteBasisdaten
Extremkurse
Indikatoren
Sektorenvergleich - Biotechnologie und medizinische Forschung - Andere
Name | % | % 5 Tage | % 1. Jan. | % 1 Jahr | Kap. | |
---|---|---|---|---|---|---|
+8.32% | -.--% | +17.44% | -3.70% | 573 Mio. | ||
+0.82% | +2.79% | +56.57% | +22.70% | 59.34 Mrd. | ||
+1.36% | +3.60% | +43.12% | -15.32% | 40.24 Mrd. | ||
-0.11% | -1.37% | -5.18% | +6.77% | 39.88 Mrd. | ||
+1.17% | +6.37% | -5.56% | +10.51% | 28.55 Mrd. | ||
-0.40% | +2.09% | +16.46% | +47.25% | 27.26 Mrd. | ||
-0.77% | +0.86% | -20.94% | -21.58% | 19.23 Mrd. | ||
-0.70% | +5.47% | +32.70% | +85.19% | 12.61 Mrd. | ||
+0.51% | +3.04% | +3.16% | -3.67% | 12.49 Mrd. | ||
+0.17% | +2.66% | +26.26% | +26.06% | 12.28 Mrd. | ||
+1.67% | +5.19% | -6.68% | +9.44% | 11.13 Mrd. | ||
-0.04% | +4.95% | -0.05% | -5.29% | 9.9 Mrd. | ||
-2.35% | +3.46% | +37.69% | +46.26% | 6.71 Mrd. | ||
-0.71% | -0.92% | +14.25% | +81.70% | 6.63 Mrd. | ||
+0.80% | -4.01% | +21.62% | -15.00% | 6.56 Mrd. | ||
-0.32% | +3.89% | +0.64% | -30.24% | 6.17 Mrd. | ||
Durchschnitt | +0.59% | +3.31% | +14.47% | +15.07% | ||
Gewichteter Durchschnitt nach Marktkapitalisierung | +0.38% | +3.42% | +19.95% | +13.82% |
Historische Daten
Datum | Eröffnung | Hoch | Tief | Schlusskurs | Volumen |
---|
Monatliche Veränderungen
Jährliche Veränderungen
2024 | +17.44% | ||
2023 | -21.15% | ||
2022 | +26.83% | ||
2021 | -32.05% | ||
2020 | +21.41% | ||
2019 | +26.01% | ||
2018 | -49.18% | ||
2017 | +9.03% | ||
2016 | -25.48% | ||
2015 | +2.41% | ||
2014 | -17.20% | ||
2013 | +144.75% | ||
2012 | +17.98% | ||
2011 | -31.88% | ||
2010 | -30.40% | ||
2009 | -39.19% | ||
2008 | -17.02% | ||
2007 | +2.77% | ||
2006 | +225.33% | ||
2004 | -3.47% |
- Börse
- Aktien
- A0B9GA Aktie
- A0B9GA Aktie
- Kurse Basilea Pharmaceutica AG